0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pharmaceutical Contract Manufacturing & Contract - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-0Y2665
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Contract Manufacturing and Contract Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Pharmaceutical Contract Manufacturing & Contract - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-0Y2665
Report
September 2024
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Contract Manufacturing & Contract - Market Size

The global market for Pharmaceutical Contract Manufacturing & Contract was estimated to be worth US$ 87830 million in 2023 and is forecast to a readjusted size of US$ 136820 million by 2030 with a CAGR of 6.4% during the forecast period 2024-2030

Pharmaceutical Contract Manufacturing & Contract - Market

Pharmaceutical Contract Manufacturing & Contract - Market

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Manufacturing & Contract, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Contract Manufacturing & Contract by region & country, by Type, and by Application.
The Pharmaceutical Contract Manufacturing & Contract market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Manufacturing & Contract.
Market Segmentation

Scope of Pharmaceutical Contract Manufacturing & Contract - Market Report

Report Metric Details
Report Name Pharmaceutical Contract Manufacturing & Contract - Market
Forecasted market size in 2030 US$ 136820 million
CAGR 6.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Manufacturing
  • Research
Segment by Application
  • Small Medium Enterprise
  • Large Enterprise
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, Pharmaceutical Product Development LLC, AbbVie, Baxter BioPharma Solutions, Patheon, Grifols International, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmBh, Lonza AG., Grifols S.A, Jubilant Life Sciences Limited, QuintilesIMS, Vetter Pharma, Ligand Pharmaceuticals, Inc., Bausch Health, Recipharm AB, Famar Health Care Services, West Pharmaceutical Services, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Pharmaceutical Contract Manufacturing & Contract manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Pharmaceutical Contract Manufacturing & Contract in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Pharmaceutical Contract Manufacturing & Contract in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Pharmaceutical Contract Manufacturing & Contract - Market size in 2030?

Ans: The Pharmaceutical Contract Manufacturing & Contract - Market size in 2030 will be US$ 136820 million.

Who are the main players in the Pharmaceutical Contract Manufacturing & Contract - Market report?

Ans: The main players in the Pharmaceutical Contract Manufacturing & Contract - Market are Catalent, Pharmaceutical Product Development LLC, AbbVie, Baxter BioPharma Solutions, Patheon, Grifols International, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmBh, Lonza AG., Grifols S.A, Jubilant Life Sciences Limited, QuintilesIMS, Vetter Pharma, Ligand Pharmaceuticals, Inc., Bausch Health, Recipharm AB, Famar Health Care Services, West Pharmaceutical Services, Inc.

What are the Application segmentation covered in the Pharmaceutical Contract Manufacturing & Contract - Market report?

Ans: The Applications covered in the Pharmaceutical Contract Manufacturing & Contract - Market report are Small Medium Enterprise, Large Enterprise

What are the Type segmentation covered in the Pharmaceutical Contract Manufacturing & Contract - Market report?

Ans: The Types covered in the Pharmaceutical Contract Manufacturing & Contract - Market report are Manufacturing, Research

1 Market Overview
1.1 Pharmaceutical Contract Manufacturing & Contract Product Introduction
1.2 Global Pharmaceutical Contract Manufacturing & Contract Market Size Forecast
1.3 Pharmaceutical Contract Manufacturing & Contract Market Trends & Drivers
1.3.1 Pharmaceutical Contract Manufacturing & Contract Industry Trends
1.3.2 Pharmaceutical Contract Manufacturing & Contract Market Drivers & Opportunity
1.3.3 Pharmaceutical Contract Manufacturing & Contract Market Challenges
1.3.4 Pharmaceutical Contract Manufacturing & Contract Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Contract Manufacturing & Contract Players Revenue Ranking (2023)
2.2 Global Pharmaceutical Contract Manufacturing & Contract Revenue by Company (2019-2024)
2.3 Key Companies Pharmaceutical Contract Manufacturing & Contract Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pharmaceutical Contract Manufacturing & Contract Product Offered
2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Contract Manufacturing & Contract
2.6 Pharmaceutical Contract Manufacturing & Contract Market Competitive Analysis
2.6.1 Pharmaceutical Contract Manufacturing & Contract Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Contract Manufacturing & Contract Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Manufacturing & Contract as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Manufacturing
3.1.2 Research
3.2 Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Type
3.2.1 Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmaceutical Contract Manufacturing & Contract Sales Value, by Type (2019-2030)
3.2.3 Global Pharmaceutical Contract Manufacturing & Contract Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Small Medium Enterprise
4.1.2 Large Enterprise
4.2 Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Application
4.2.1 Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pharmaceutical Contract Manufacturing & Contract Sales Value, by Application (2019-2030)
4.2.3 Global Pharmaceutical Contract Manufacturing & Contract Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Region
5.1.1 Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Region (2019-2024)
5.1.3 Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Region (2025-2030)
5.1.4 Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
5.2.2 North America Pharmaceutical Contract Manufacturing & Contract Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
5.3.2 Europe Pharmaceutical Contract Manufacturing & Contract Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
5.4.2 Asia Pacific Pharmaceutical Contract Manufacturing & Contract Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
5.5.2 South America Pharmaceutical Contract Manufacturing & Contract Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
5.6.2 Middle East & Africa Pharmaceutical Contract Manufacturing & Contract Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Contract Manufacturing & Contract Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmaceutical Contract Manufacturing & Contract Sales Value
6.3 United States
6.3.1 United States Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
6.3.2 United States Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmaceutical Contract Manufacturing & Contract Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
6.4.2 Europe Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmaceutical Contract Manufacturing & Contract Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
6.5.2 China Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmaceutical Contract Manufacturing & Contract Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
6.6.2 Japan Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmaceutical Contract Manufacturing & Contract Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
6.7.2 South Korea Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmaceutical Contract Manufacturing & Contract Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmaceutical Contract Manufacturing & Contract Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019-2030
6.9.2 India Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmaceutical Contract Manufacturing & Contract Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Catalent
7.1.1 Catalent Profile
7.1.2 Catalent Main Business
7.1.3 Catalent Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.1.4 Catalent Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.1.5 Catalent Recent Developments
7.2 Pharmaceutical Product Development LLC
7.2.1 Pharmaceutical Product Development LLC Profile
7.2.2 Pharmaceutical Product Development LLC Main Business
7.2.3 Pharmaceutical Product Development LLC Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.2.4 Pharmaceutical Product Development LLC Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.2.5 Pharmaceutical Product Development LLC Recent Developments
7.3 AbbVie
7.3.1 AbbVie Profile
7.3.2 AbbVie Main Business
7.3.3 AbbVie Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.3.4 AbbVie Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.3.5 Baxter BioPharma Solutions Recent Developments
7.4 Baxter BioPharma Solutions
7.4.1 Baxter BioPharma Solutions Profile
7.4.2 Baxter BioPharma Solutions Main Business
7.4.3 Baxter BioPharma Solutions Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.4.4 Baxter BioPharma Solutions Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.4.5 Baxter BioPharma Solutions Recent Developments
7.5 Patheon
7.5.1 Patheon Profile
7.5.2 Patheon Main Business
7.5.3 Patheon Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.5.4 Patheon Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.5.5 Patheon Recent Developments
7.6 Grifols International
7.6.1 Grifols International Profile
7.6.2 Grifols International Main Business
7.6.3 Grifols International Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.6.4 Grifols International Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.6.5 Grifols International Recent Developments
7.7 Dalton Pharma Services
7.7.1 Dalton Pharma Services Profile
7.7.2 Dalton Pharma Services Main Business
7.7.3 Dalton Pharma Services Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.7.4 Dalton Pharma Services Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.7.5 Dalton Pharma Services Recent Developments
7.8 Boehringer Ingelheim Biopharmaceuticals GmBh
7.8.1 Boehringer Ingelheim Biopharmaceuticals GmBh Profile
7.8.2 Boehringer Ingelheim Biopharmaceuticals GmBh Main Business
7.8.3 Boehringer Ingelheim Biopharmaceuticals GmBh Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.8.4 Boehringer Ingelheim Biopharmaceuticals GmBh Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.8.5 Boehringer Ingelheim Biopharmaceuticals GmBh Recent Developments
7.9 Lonza AG.
7.9.1 Lonza AG. Profile
7.9.2 Lonza AG. Main Business
7.9.3 Lonza AG. Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.9.4 Lonza AG. Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.9.5 Lonza AG. Recent Developments
7.10 Grifols S.A
7.10.1 Grifols S.A Profile
7.10.2 Grifols S.A Main Business
7.10.3 Grifols S.A Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.10.4 Grifols S.A Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.10.5 Grifols S.A Recent Developments
7.11 Jubilant Life Sciences Limited
7.11.1 Jubilant Life Sciences Limited Profile
7.11.2 Jubilant Life Sciences Limited Main Business
7.11.3 Jubilant Life Sciences Limited Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.11.4 Jubilant Life Sciences Limited Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.11.5 Jubilant Life Sciences Limited Recent Developments
7.12 QuintilesIMS
7.12.1 QuintilesIMS Profile
7.12.2 QuintilesIMS Main Business
7.12.3 QuintilesIMS Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.12.4 QuintilesIMS Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.12.5 QuintilesIMS Recent Developments
7.13 Vetter Pharma
7.13.1 Vetter Pharma Profile
7.13.2 Vetter Pharma Main Business
7.13.3 Vetter Pharma Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.13.4 Vetter Pharma Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.13.5 Vetter Pharma Recent Developments
7.14 Ligand Pharmaceuticals, Inc.
7.14.1 Ligand Pharmaceuticals, Inc. Profile
7.14.2 Ligand Pharmaceuticals, Inc. Main Business
7.14.3 Ligand Pharmaceuticals, Inc. Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.14.4 Ligand Pharmaceuticals, Inc. Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.14.5 Ligand Pharmaceuticals, Inc. Recent Developments
7.15 Bausch Health
7.15.1 Bausch Health Profile
7.15.2 Bausch Health Main Business
7.15.3 Bausch Health Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.15.4 Bausch Health Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.15.5 Bausch Health Recent Developments
7.16 Recipharm AB
7.16.1 Recipharm AB Profile
7.16.2 Recipharm AB Main Business
7.16.3 Recipharm AB Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.16.4 Recipharm AB Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.16.5 Recipharm AB Recent Developments
7.17 Famar Health Care Services
7.17.1 Famar Health Care Services Profile
7.17.2 Famar Health Care Services Main Business
7.17.3 Famar Health Care Services Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.17.4 Famar Health Care Services Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.17.5 Famar Health Care Services Recent Developments
7.18 West Pharmaceutical Services, Inc.
7.18.1 West Pharmaceutical Services, Inc. Profile
7.18.2 West Pharmaceutical Services, Inc. Main Business
7.18.3 West Pharmaceutical Services, Inc. Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
7.18.4 West Pharmaceutical Services, Inc. Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2019-2024)
7.18.5 West Pharmaceutical Services, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical Contract Manufacturing & Contract Industrial Chain
8.2 Pharmaceutical Contract Manufacturing & Contract Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Contract Manufacturing & Contract Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Contract Manufacturing & Contract Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Pharmaceutical Contract Manufacturing & Contract Market Trends
    Table 2. Pharmaceutical Contract Manufacturing & Contract Market Drivers & Opportunity
    Table 3. Pharmaceutical Contract Manufacturing & Contract Market Challenges
    Table 4. Pharmaceutical Contract Manufacturing & Contract Market Restraints
    Table 5. Global Pharmaceutical Contract Manufacturing & Contract Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pharmaceutical Contract Manufacturing & Contract Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Pharmaceutical Contract Manufacturing & Contract Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Pharmaceutical Contract Manufacturing & Contract Product Type
    Table 9. Key Companies Time to Begin Mass Production of Pharmaceutical Contract Manufacturing & Contract
    Table 10. Global Pharmaceutical Contract Manufacturing & Contract Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Manufacturing & Contract as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Pharmaceutical Contract Manufacturing & Contract Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Pharmaceutical Contract Manufacturing & Contract Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Pharmaceutical Contract Manufacturing & Contract Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Pharmaceutical Contract Manufacturing & Contract Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Region (2019-2024) & (%)
    Table 27. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Pharmaceutical Contract Manufacturing & Contract Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Pharmaceutical Contract Manufacturing & Contract Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Pharmaceutical Contract Manufacturing & Contract Sales Value, (2025-2030) & (US$ Million)
    Table 31. Catalent Basic Information List
    Table 32. Catalent Description and Business Overview
    Table 33. Catalent Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Catalent (2019-2024)
    Table 35. Catalent Recent Developments
    Table 36. Pharmaceutical Product Development LLC Basic Information List
    Table 37. Pharmaceutical Product Development LLC Description and Business Overview
    Table 38. Pharmaceutical Product Development LLC Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Pharmaceutical Product Development LLC (2019-2024)
    Table 40. Pharmaceutical Product Development LLC Recent Developments
    Table 41. AbbVie Basic Information List
    Table 42. AbbVie Description and Business Overview
    Table 43. AbbVie Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of AbbVie (2019-2024)
    Table 45. AbbVie Recent Developments
    Table 46. Baxter BioPharma Solutions Basic Information List
    Table 47. Baxter BioPharma Solutions Description and Business Overview
    Table 48. Baxter BioPharma Solutions Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Baxter BioPharma Solutions (2019-2024)
    Table 50. Baxter BioPharma Solutions Recent Developments
    Table 51. Patheon Basic Information List
    Table 52. Patheon Description and Business Overview
    Table 53. Patheon Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Patheon (2019-2024)
    Table 55. Patheon Recent Developments
    Table 56. Grifols International Basic Information List
    Table 57. Grifols International Description and Business Overview
    Table 58. Grifols International Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Grifols International (2019-2024)
    Table 60. Grifols International Recent Developments
    Table 61. Dalton Pharma Services Basic Information List
    Table 62. Dalton Pharma Services Description and Business Overview
    Table 63. Dalton Pharma Services Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Dalton Pharma Services (2019-2024)
    Table 65. Dalton Pharma Services Recent Developments
    Table 66. Boehringer Ingelheim Biopharmaceuticals GmBh Basic Information List
    Table 67. Boehringer Ingelheim Biopharmaceuticals GmBh Description and Business Overview
    Table 68. Boehringer Ingelheim Biopharmaceuticals GmBh Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Boehringer Ingelheim Biopharmaceuticals GmBh (2019-2024)
    Table 70. Boehringer Ingelheim Biopharmaceuticals GmBh Recent Developments
    Table 71. Lonza AG. Basic Information List
    Table 72. Lonza AG. Description and Business Overview
    Table 73. Lonza AG. Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Lonza AG. (2019-2024)
    Table 75. Lonza AG. Recent Developments
    Table 76. Grifols S.A Basic Information List
    Table 77. Grifols S.A Description and Business Overview
    Table 78. Grifols S.A Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Grifols S.A (2019-2024)
    Table 80. Grifols S.A Recent Developments
    Table 81. Jubilant Life Sciences Limited Basic Information List
    Table 82. Jubilant Life Sciences Limited Description and Business Overview
    Table 83. Jubilant Life Sciences Limited Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Jubilant Life Sciences Limited (2019-2024)
    Table 85. Jubilant Life Sciences Limited Recent Developments
    Table 86. QuintilesIMS Basic Information List
    Table 87. QuintilesIMS Description and Business Overview
    Table 88. QuintilesIMS Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of QuintilesIMS (2019-2024)
    Table 90. QuintilesIMS Recent Developments
    Table 91. Vetter Pharma Basic Information List
    Table 92. Vetter Pharma Description and Business Overview
    Table 93. Vetter Pharma Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Vetter Pharma (2019-2024)
    Table 95. Vetter Pharma Recent Developments
    Table 96. Ligand Pharmaceuticals, Inc. Basic Information List
    Table 97. Ligand Pharmaceuticals, Inc. Description and Business Overview
    Table 98. Ligand Pharmaceuticals, Inc. Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Ligand Pharmaceuticals, Inc. (2019-2024)
    Table 100. Ligand Pharmaceuticals, Inc. Recent Developments
    Table 101. Bausch Health Basic Information List
    Table 102. Bausch Health Description and Business Overview
    Table 103. Bausch Health Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Bausch Health (2019-2024)
    Table 105. Bausch Health Recent Developments
    Table 106. Recipharm AB Basic Information List
    Table 107. Recipharm AB Description and Business Overview
    Table 108. Recipharm AB Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Recipharm AB (2019-2024)
    Table 110. Recipharm AB Recent Developments
    Table 111. Famar Health Care Services Basic Information List
    Table 112. Famar Health Care Services Description and Business Overview
    Table 113. Famar Health Care Services Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of Famar Health Care Services (2019-2024)
    Table 115. Famar Health Care Services Recent Developments
    Table 116. West Pharmaceutical Services, Inc. Basic Information List
    Table 117. West Pharmaceutical Services, Inc. Description and Business Overview
    Table 118. West Pharmaceutical Services, Inc. Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Pharmaceutical Contract Manufacturing & Contract Business of West Pharmaceutical Services, Inc. (2019-2024)
    Table 120. West Pharmaceutical Services, Inc. Recent Developments
    Table 121. Key Raw Materials Lists
    Table 122. Raw Materials Key Suppliers Lists
    Table 123. Pharmaceutical Contract Manufacturing & Contract Downstream Customers
    Table 124. Pharmaceutical Contract Manufacturing & Contract Distributors List
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
    Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Pharmaceutical Contract Manufacturing & Contract Product Picture
    Figure 2. Global Pharmaceutical Contract Manufacturing & Contract Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pharmaceutical Contract Manufacturing & Contract Sales Value (2019-2030) & (US$ Million)
    Figure 4. Pharmaceutical Contract Manufacturing & Contract Report Years Considered
    Figure 5. Global Pharmaceutical Contract Manufacturing & Contract Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Contract Manufacturing & Contract Revenue in 2023
    Figure 7. Pharmaceutical Contract Manufacturing & Contract Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Manufacturing Picture
    Figure 9. Research Picture
    Figure 10. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Pharmaceutical Contract Manufacturing & Contract Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Small Medium Enterprise
    Figure 13. Product Picture of Large Enterprise
    Figure 14. Global Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Pharmaceutical Contract Manufacturing & Contract Sales Value Market Share by Application, 2023 & 2030
    Figure 16. North America Pharmaceutical Contract Manufacturing & Contract Sales Value (2019-2030) & (US$ Million)
    Figure 17. North America Pharmaceutical Contract Manufacturing & Contract Sales Value by Country (%), 2023 VS 2030
    Figure 18. Europe Pharmaceutical Contract Manufacturing & Contract Sales Value (2019-2030) & (US$ Million)
    Figure 19. Europe Pharmaceutical Contract Manufacturing & Contract Sales Value by Country (%), 2023 VS 2030
    Figure 20. Asia Pacific Pharmaceutical Contract Manufacturing & Contract Sales Value (2019-2030) & (US$ Million)
    Figure 21. Asia Pacific Pharmaceutical Contract Manufacturing & Contract Sales Value by Country (%), 2023 VS 2030
    Figure 22. South America Pharmaceutical Contract Manufacturing & Contract Sales Value (2019-2030) & (US$ Million)
    Figure 23. South America Pharmaceutical Contract Manufacturing & Contract Sales Value by Country (%), 2023 VS 2030
    Figure 24. Middle East & Africa Pharmaceutical Contract Manufacturing & Contract Sales Value (2019-2030) & (US$ Million)
    Figure 25. Middle East & Africa Pharmaceutical Contract Manufacturing & Contract Sales Value by Country (%), 2023 VS 2030
    Figure 26. Key Countries/Regions Pharmaceutical Contract Manufacturing & Contract Sales Value (%), (2019-2030)
    Figure 27. United States Pharmaceutical Contract Manufacturing & Contract Sales Value, (2019-2030) & (US$ Million)
    Figure 28. United States Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
    Figure 29. United States Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (%), 2023 VS 2030
    Figure 30. Europe Pharmaceutical Contract Manufacturing & Contract Sales Value, (2019-2030) & (US$ Million)
    Figure 31. Europe Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
    Figure 32. Europe Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (%), 2023 VS 2030
    Figure 33. China Pharmaceutical Contract Manufacturing & Contract Sales Value, (2019-2030) & (US$ Million)
    Figure 34. China Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
    Figure 35. China Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (%), 2023 VS 2030
    Figure 36. Japan Pharmaceutical Contract Manufacturing & Contract Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Japan Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
    Figure 38. Japan Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (%), 2023 VS 2030
    Figure 39. South Korea Pharmaceutical Contract Manufacturing & Contract Sales Value, (2019-2030) & (US$ Million)
    Figure 40. South Korea Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
    Figure 41. South Korea Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (%), 2023 VS 2030
    Figure 42. Southeast Asia Pharmaceutical Contract Manufacturing & Contract Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
    Figure 44. Southeast Asia Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (%), 2023 VS 2030
    Figure 45. India Pharmaceutical Contract Manufacturing & Contract Sales Value, (2019-2030) & (US$ Million)
    Figure 46. India Pharmaceutical Contract Manufacturing & Contract Sales Value by Type (%), 2023 VS 2030
    Figure 47. India Pharmaceutical Contract Manufacturing & Contract Sales Value by Application (%), 2023 VS 2030
    Figure 48. Pharmaceutical Contract Manufacturing & Contract Industrial Chain
    Figure 49. Pharmaceutical Contract Manufacturing & Contract Manufacturing Cost Structure
    Figure 50. Channels of Distribution (Direct Sales, and Distribution)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Smart Pills and Drugs Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-5Q14261
Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Grade Silica - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38W13955
Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Pharma Grade Sodium Hydroxide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-30U13946
Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Sorbitol Liquid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-23N13862
Fri Nov 22 00:00:00 UTC 2024

Add to Cart